We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Premier Veterinary Group Plc | LSE:PVG | London | Ordinary Share | GB00BSZLMS59 | ORD 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 34.50 | 32.00 | 37.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Jul 2019 to Jul 2024
TIDMAKT
RNS Number : 6662D
Ark Therapeutics Group PLC
18 May 2012
18 May 2012
Ark Therapeutics Group plc
Directors' Share Dealing
Ark Therapeutics Group plc (LSE: AKT) ("the "Company") has received notification that on 17 May 2012 Peter Keen, Non-Executive Director, purchased 750,000 ordinary shares of 1 pence each in the Company through his Self Invested Pension Plan at a price of 2.85 pence per share.
As previously announced, Peter Keen retired as a Director with effect from the conclusion of yesterday's Annual General Meeting of the Company.
For further information please contact:
Ark Therapeutics Group plc Dr Edward Bliss, Company Secretary +44 (0)20 7388 7722
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSKMGMKGRRGZZM
1 Year Premier Veterinary Chart |
1 Month Premier Veterinary Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
